RTRAF
RNA transcription, translation and transport factor protein
Also known as: C14orf166, CGI-99, CLE, CLE7, hCLE1, LCRP369, RLLM1, RTRAF_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y224
- Gene
- RTRAF
- Ensembl
- ENSG00000087302
- Chromosome
- 14
- Canonical length
- 244 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables RNA binding activity; RNA polymerase II complex binding activity; and identical protein binding activity. Involved in negative regulation of protein kinase activity; positive regulation of transcription by RNA polymerase II; and tRNA splicing, via endonucleolytic cleavage and ligation. Located in microtubule cytoskeleton; nucleoplasm; and perinuclear region of cytoplasm. Part of tRNA-splicing ligase complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
244 residues, UniProt reviewed canonical sequence.
>Q9Y224|RTRAF
1 MFRRKLTALD YHNPAGFNCK DETEFRNFIV WLEDQKIRHY KIEDRGNLRN IHSSDWPKFF
61 EKYLRDVNCP FKIQDRQEAI DWLLGLAVRL EYGDNAEKYK DLVPDNSKTA DNATKNAEPL
121 INLDVNNPDF KAGVMALANL LQIQRHDDYL VMLKAIRILV QERLTQDAVA KANQTKEGLP
181 VALDKHILGF DTGDAVLNEA AQILRLLHIE ELRELQTKIN EAIVAVQAII ADPKTDHRLG
241 KVGRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RTRAF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 150 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 150 nTPM
- heart muscle: 143 nTPM
- testis: 133 nTPM
- bone marrow: 131 nTPM
- pancreas: 108 nTPM
- thymus: 100 nTPM
Single-cell type
- late primary spermatocytes: 1,027 nCPM
- oocytes: 843 nCPM
- late spermatids: 825 nCPM
- early spermatids: 598 nCPM
- esophageal suprabasal cells: 430 nCPM
- extravillous trophoblasts: 426 nCPM
Immune cell
- T-reg: 144 nTPM
- total PBMC: 127 nTPM
- myeloid DC: 118 nTPM
- non-classical monocyte: 113 nTPM
- memory B-cell: 109 nTPM
- plasmacytoid DC: 108 nTPM
Brain region
- white matter: 40 nTPM
- choroid plexus: 37 nTPM
- spinal cord: 35 nTPM
- hypothalamus: 34 nTPM
- cerebellum: 33 nTPM
- medulla oblongata: 33 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0.2
- DepMap mean gene effect
- -0.38
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of protein kinase activity
- positive regulation of transcription by RNA polymerase II
- RNA transport
- tRNA splicing, via endonucleolytic cleavage and ligation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA transcription, translation and transport factor protein
- RNA transcription, translation and transport factor protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RTRAF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RTRAF as an antibody target. Whether an autoantibody or antibody against RTRAF could matter depends on whether native RTRAF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RTRAF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RTRAF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...